
Cost-effectiveness analysis of dapagliflozin in addition to standard therapy in heart failure with reduced ejection fraction: A Qatari healthcare perspective
Author(s) -
Daoud AlBadriyeh,
Salma Chbib,
Palli Valapila Abdulrouf,
Moza Al Hail,
Wessam El Kassem,
Dina Abushanab
Publication year - 2022
Publication title -
journal of emergency medicine, trauma and acute care
Language(s) - English
Resource type - Journals
eISSN - 1999-7094
pISSN - 1999-7086
DOI - 10.5339/jemtac.2022.qhc.62
Subject(s) - dapagliflozin , ejection fraction , medicine , heart failure , intensive care medicine , cardiology , diabetes mellitus , type 2 diabetes , endocrinology